Enora Laas

13PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyHaematological tumoursMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 19, 2026
H3K4me1-Mediated Epigenomic Priming of Chemoresistant Tumor States in Ovarian Cancer.

|Jul 07, 2026
Efficacy of secondary cytoreductive surgery for relapsed ovarian low-grade serous carcinoma: a multicenter analysis from French TMRG network.

|Sep 26, 2025
Impact of Antihypertensive Treatment on Outcomes of Adjuvant Bevacizumab for Ovarian Cancer (IATRO), Results from a Nationwide Emulated Clinical Trial.

Floriane Jochum, Élise Dumas, Joe-Elie Salem

|Aug 24, 2025
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2- Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial.

Enora Laas, Anne-Sophie Hamy, Thomas Bachelot

|May 29, 2025
BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase.

Aurélie Cabannes-Hamy, Rayan Kabirian, Floriane Jochum

|Apr 13, 2024
Cervical Cancer Associated with Pregnancy: Current Challenges and Future Strategies.

Jennifer Le Guévelou, Lise Selleret, Enora Laas

Pageof 3

Frequent Collaborators

4 joint publications

Floriane Jochum

4 joint publications

Paul Gougis

4 joint publications

Anne-Sophie Hamy

4 joint publications

Fabrice Lecuru